Zinc oxide nanoparticles for therapeutic purposes in cancer medicine (original) (raw)

Author affiliations

* Corresponding authors

a Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Centre of the Johannes Gutenberg-University, Laboratory for Molecular Tumor Biology, Langenbeckstraße 1, 55131 Mainz, Germany
E-mail: nwiesman@uni-mainz.de

b Department of Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, 55128 Mainz, Germany

Abstract

The importance of zinc as a trace metal in the human body has long been overlooked. We now gradually discover that the impact of zinc on the health of our body might be as far-reaching as that of iron. Concurrently, nanomaterials containing zinc, in particular zinc oxide nanoparticles (ZnO NPs), are becoming increasingly attractive as innovative agents for medical applications. Zinc oxide is characterized by a good biocompatibility which allows the exploitation of its antibacterial, antifungal, antiviral, and anti-cancer qualities in a therapeutic setting. This perspective outlines the current state of knowledge concerning the interaction of zinc oxide nanoparticles with eukaryotic cells and the human body. Furthermore, it sheds light on the importance of zinc under physiological conditions. This helps to place the in vivo behavior of zinc oxide nanoparticles in the proper context. We evaluate the potential of zinc oxide nanoparticles as innovative anti-tumor agents by summarizing important results of current studies in this field and discuss the proposed mechanisms that give zinc oxide nanoparticles a selective toxicity for tumor cells.

Graphical abstract: Zinc oxide nanoparticles for therapeutic purposes in cancer medicine

You have access to this article

Please wait while we load your content... Something went wrong. Try again?

Article information

DOI

https://doi.org/10.1039/D0TB00739K

Article type

Review Article

Submitted

18 Mar 2020

Accepted

08 May 2020

First published

19 May 2020

Download Citation

J. Mater. Chem. B, 2020,8, 4973-4989

Permissions

Zinc oxide nanoparticles for therapeutic purposes in cancer medicine

N. Wiesmann, W. Tremel and J. Brieger,J. Mater. Chem. B, 2020, 8, 4973DOI: 10.1039/D0TB00739K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements